TNFRSF19 is overexpressed in glioblastoma correlating with tumor grade [67], in myeloproliferative neoplasms [68], melanoma [69], lung cancer [70], and nasopharyngeal carcinoma where it is required for cell proliferation [34]. Here, TNFRSF19 is linked to myeloproliferative neoplasm.